×
Back to Agenda
SESSION 4: FACILITATION OUTSIDE THE REGULATORY WORLD
Session Chair(s)
Representative Invited
University Freiburg Inst. F.Pharmaceutical Sciences, Germany
Facilitation Outside the Regulatory World
Speaker(s)
Martine Dehlinger-Kremer, PHD
Sn Drug Development Strategy Lead Pediatrics, UCB Biosciences, Germany
CRO’s Perspective on Feasibility and Challenges with Paediatric Clinical Trials
Mark Turner, MD, PHD, MRCP, FFPM
Chief Executive Officer of the c4c- Stichting (c4c-S) & Professor of Neonatology, University of Liverpool, United Kingdom
HCP Voice on Practical Challenges/Suggestions
William R. Treem
Senior Director, Pediatric Drug Development, Janssen Pharmaceutical Research and Development, United States
The Case for a Global Pediatric Clinical Trials Network; and Progress Towards that Goal
Have an account?